Indications |
Oral Endometriosis Adult: 10 mg bid-tid cyclically or continuously. Oral Recurrent miscarriage Adult: 10 mg bid given cyclically until conception, then continuously until wk 20 of pregnancy, after which dose may be gradually reduced. Oral Menstrual disorders Adult: 10 mg bid in a cyclical regimen. Oral Threatened miscarriage Adult: Initially, 40 mg followed by 10 mg or more every 8 hr, continued for a wk after symptoms are relieved. Reduce dose gradually after that unless symptoms return. Oral Infertility Adult: 10 mg bid. Oral Endometrial protection during menopausal hormonal replacement therapy Adult: 10 mg 1-2 times daily in a cyclical regimen or 5 mg daily. |
Contraindications |
Hypersensitivity; pregnancy. Undiagnosed abnormal vag bleeding, thromboembolic disorders, history or existing cerebrovascular or coronary artery disease, missed or incomplete abortion, known or suspected carcinoma of the breast or genital organs, severe hepatic dysfunction, as a diagnostic test for pregnancy. |
Warnings / Precautions |
Monitor closely for loss of vision, proptosis, diplopia, migraine, signs and symptoms of embolic disorders. CVD or renal impairment, epilepsy, asthma, other conditions which may be aggravated by fluid retention. Lactation. |
Adverse Reactions |
Dizziness, nausea, headache, fatigue, emotional lability, irritability; abdominal pain and distention; muskuloskeletal pain. |
Drug Interactions |
Carbamazepine, griseofulvin, phenobarbital, rifampicin enhances the clearance of progestogens. See Below for More dydrogesterone Drug Interactions |
Lab Interactions |
Altered serum-lipid profile and liver function tests. |
Mechanism of Actions |
Dydrogesterone is a progestogen structurally related to progesterone. However, unlike progesterone, it does not induce an increase in temp nor inhibit ovulation and may be preferred over other progestational agents when contraceptive effect is not required. It does not have oestrogenic or androgenic properties. Absorption: Absorbed following buccal, rectal, and vag administration; rapidly absorbed following (IM). Metabolism: Hepatic: Extensive first-pass effect. Excretion: Via urine (as sulfate and glucuronide conjugates). |
Administration |
May be taken with or without food. |
ATC Classification |
G03DB01 - dydrogesterone ; Belongs to the class of pregnadien derivative progestogens used in progestogenic hormone preparations. |
Available As |
|
Dydrogesterone
Post Review about Dydrogesterone Click here to cancel reply.
Dydrogesterone Containing Brands
Dydrogesterone is used in following diseases
Drug - Drug Interactions of Dydrogesterone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.